Novel is not a quality judgement
Among other criteria, the European novel food framework considers the history of significant consumption within the Union before 15 May 1997. The classification does not, in itself, mean an ingredient is better or worse. It indicates that the applicable procedure must be followed before marketing it for the relevant uses.
The Commission maintains a Novel Food Status Catalogue as a guidance tool. This catalogue should not be confused with the Union list of authorised novel foods. The resources have different functions: one helps examine novel food status; the other records authorisations and their conditions. Opening a database is not enough: we need to know which one we are consulting.
An application is not the outcome
A dossier may appear in a list of applications because a company has initiated a procedure. That does not mean the ingredient is authorised. Publication provides transparency about what has been requested, but does not turn the applicant's proposals into legally approved conditions. Even a technically detailed description may still belong to that stage.
The same applies to a favourable scientific opinion. It is an important part of the procedure, but does not replace the required authorisation act. The Commission explains that lawful marketing follows adoption and publication of the act, under its specified conditions. In accurate reporting, the subject and verb matter as much as the ingredient's name.
Authorisation would not be an unlimited label either
Conditions and specifications form part of an authorisation. A decision about one particular preparation should therefore not be transferred automatically to another with a different composition or use. CBD is the subject of a broad conversation, while a dossier needs a precise description of what it assesses.
Imagine a hypothetical specification defining a substance with particular characteristics. Finding the same name on a container does not establish that its contents meet those specifications. Documents and product would need to be compared. This example does not anticipate any authorisation: it explains why even positive news requires reading the wording that defines its scope.
Following developments without losing your way
When you find a headline, note who issued it, which application or act it identifies, what stage it has reached and which product it describes. Then consult the Union list and the competent authority's sources. Products being on sale or opinions appearing on social media cannot replace that check. Understanding Novel Food lets us recognise real progress without attributing legal effects it does not yet have.
A personal table of those four stages helps prevent progress in one dossier from being mistaken for the final outcome of all the others.
Take this with you
Catalogue, application, opinion and authorisation are different elements; the specific conditions always matter.
Sources you can open
The source may be in its original language. English publication does not change the jurisdiction or date discussed.
Follow the thread
Open the cannabinoid encyclopedia
Check the identity, research, uncertainties and documented forms of each compound.